stars 1 stars 2 stars 3

Vivtex originated from MIT, with a mission to enable the development of new oral drugs using sophisticated high throughput screening technologies, IP protected formulation libraries and molecular modeling/AI techniques. Vivtex has R&D collaborations with leading biotechnology and pharmaceutical companies with several oral peptide programs at the pre-clinical to clinical stage. Our vision is to empower patients with a choice of how to take their medicine.

Vivtex Questions

The Vivtex annual revenue was $2 million in 2026.

Thomas von Erlach is the Co-Founder and CEO of Vivtex.

18 people are employed at Vivtex.

Vivtex is based in Boston, Massachusetts.

The NAICS codes for Vivtex are [325, 32, 32541, 3254].

The SIC codes for Vivtex are [283, 2834, 28].

Top Vivtex Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users